|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/15 | (2015.01) |
| A61K 35/15 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/5156 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/5158 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 38/177 | (2013.01) | ||
| A61K 39/001126 | (2018.08) |
| (11) | Number of the document | 3895712 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21160170.3 |
| Date of filing the European patent application | 2017-12-11 | |
| (97) | Date of publication of the European application | 2021-10-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201662432302 P | 2016-12-09 | US |
| (72) |
O'DWYER, Michael Eamon Peter , IE
|
| (73) |
ONK Therapeutics Limited ,
C/O Coll & Company
Pier Road
Barna Village, Co. Galway H91 V6KV,
IE
|
| (54) | ENGINEERED NATURAL KILLER CELLS AND USES THEREOF |
| ENGINEERED NATURAL KILLER CELLS AND USES THEREOF |